Thursday, December 13, 2018

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (NYSE: $ACB) (TSX: $ACB) (TSXV: $VFF.V) (CSE: $CROP.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $VGW.C)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (NYSE: $ACB) (TSX: $ACB) (TSXV: $VFF.V) (CSE: $CROP.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $VGW.C)

This month’s cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa

Delta, Kelowna, BC - December 13, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.

https://www.investorideas.com/Audio/Podcasts/2018/121318-StocksToWatch.mp3

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (NYSE: $ACB) (TSX: $ACB) (TSXV: $VFF.V) (CSE: $CROP.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $VGW.C)

December 13, 2018

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.

This month's podcast is brought to you by our exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.

Today we are looking at announcements from Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Village Farms International, Inc. (TSX:VFF) (OTCQX:VFFIF), CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTC: CRXPF), Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), Valens GroWorks Corp. (CSE: VGW) (OTC: MYMSF) and Cannvas MedTech Inc. (CSE: MTEC).

Aurora Cannabis Inc. announced today that it has entered into an agreement to invest $10 million by way of brokered private placement in High Tide Inc., a privately held, Alberta-based, retail-focused cannabis and lifestyle accessories company. In total, Aurora will receive 10,000 senior unsecured convertible debentures issued by High Tide priced at $1,000 per debenture, bearing an interest rate of 8.5% per annum, and convertible in aggregate to 13,333,333 common shares of High Tide at $0.75 per share (the "Transaction").

High Tide is developing an expanding network across Canada of cannabis and cannabis accessory retail stores, as well as manufacturing and distributing branded cannabis accessories which positions it exceptionally well to capitalize on the Canadian adult-use cannabis industry. Through its two wholesale businesses, Famous Brandz and RGR Canada, and the 19 existing Smoker's Corner retail locations, High Tide serves more than 170,000 retail customers per year. Through Canna Cabana and eventually KushBar, High Tide currently operates 4 retail stores in Alberta, with additional leases secured with the intention of opening new locations across Canada in the near future.

Village Farms International, Inc. today announced that, following yesterday's passage by U.S. Congress of the 2018 Farm Bill, it will aggressively pursue opportunities to become a vertically integrated leader in the legal hemp industry, including significant opportunities in the cannabidiol (CBD) market. The 2018 Farm Bill is still to be signed into law by President Trump, which is expected to occur next week.

The 2018 Farm Bill includes the Hemp Farming Act 2018 which federally legalizes hemp and hemp products in the U.S., including extracts, derivatives and cannabinoids, and permanently removes hemp from the U.S. federal Controlled Substances Act (CSA). CBD has become increasingly popular among consumers seeking to improve their general health and wellness. According to Brightfield Group, with the full federal legalization of hemp-derived CBD in the U.S., the global hemp CBD market is estimated to grow nearly 40-fold in the next four years to US$22 billion in 2021, driven to a large degree by what it believes could be "the next major nutraceutical phenomenon".

"The full and unambiguous legalization of hemp, and especially hemp-derived CBD products, creates a tremendous global opportunity and Village Farms intends to be a leader in this nascent industry," said Michael DeGiglio, Chief Executive Officer, Village Farms. "With one of the largest existing greenhouse footprints in the U.S. and a 30-year proven track record as a large-scale, low-cost grower of high-value crops, Village Farms has a formidable platform to capitalize on the hemp and CBD opportunity. In anticipation of the passage of this landmark legislation, over the last several months, we have undertaken broad and extensive foundational work to ensure Village Farms can move quickly, aggressively and profoundly."

CROP INFRASTRUCTURE CORP. announced today its large Italian CBD greenhouse facility has been upgraded and is ready for the start of the 2019 growing season.

The joint venture facility, which covers 87,120 square feet and is co-owned through XHemplar S.R.L, now has a perimeter security fence being erected as well as and a comprehensive CCTV security system that is expected to be completed imminently.

CROP and XHemplar are currently working with Italian agencies to import new and unique, high CBD genetics to populate its upgraded facility that are expected to command premium prices. Discussions are also continuing with an Italy-based pharmaceutical company to secure off-take agreements for the 2019 harvests.

In addition, CROP and XHemplar have identified six potential retail locations throughout Italy and are in negotiations to open two of the retail locations shortly. It is also planned to build a state-of-the-art extraction facility that would add significant value by allowing for in-house processing of hemp biomass.

CROP Infrastructure CEO, Michael Yorke, stated: "Italy is our bridgehead into Europe. Our Italian partners are making significant progress on multiple fronts to ensure that the European operations are running at full capacity to take full advantage of the rapidly growing demand there.

Canopy Growth Corporation announced today that it has entered into a multi-year extraction agreement with Valens GroWorks Corp., a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification.

Under the terms of the multi-year agreement, Valens will utilize their proprietary technology and methodologies to process the Company's whole flower and trim into high-grade cannabis resin. Canopy Growth expects the first shipment of product for extraction will occur before the end of December 2018.

Valens previously joined Canopy Growth's CraftGrow program in October 2017. CraftGrow provides craft cannabis producers with the opportunity to bring unique cannabis products to market through the Company's leading sales channels. Having recently received its cultivation licence, Valens expects to have its first branded products available via CraftGrow for the medical and recreational markets by the end of March 2019.

"Diversifying our extraction supply capabilities with Valens, a company positioning itself as a specialized extractor, increases our ability to supply a consistent, high-quality inventory of oils for products such as Softgels," commented Mark Zekulin, President & Co-CEO, Canopy Growth. "We're also excited to see Valens progress in its licensing capabilities so that it can add its products to our CraftGrow program, increasing the diversity of high-quality cannabis products available for medical and recreational customers in 2019."

Cannvas MedTech Inc., announced that its online learning platform Cannvas.Me will be featured in an upcoming installment of Canadian Health and Family.

"Presenting our Cannvas.Me platform on this popular health and wellness program is a strong opportunity to share our free and unbiased digital cannabis education resource to a wide swath of Canadians who may be curious about using cannabis as an alternative therapeutic treatment," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "Canadian Health and Family enjoys an engaged following both online and on television, reaching beyond its viewership to contribute to conversations by family physicians and general practitioners throughout Canada, and affecting advocacy groups and resource organizations such as the Chronic Pain Association of Canada. As cannabis becomes a more prevalent part of people's health care regimen, it's imperative Canadians know where to turn for accessible and reliable physician-backed cannabis information and education."

The program makes note of the independent Medical Advisory Board and Educational Advisory Panel who steer content for Cannvas.Me and pays special attention to the platform's global reach, from its founders' travels across the world to determine how best to approach cannabis education to the site's scalability across different countries as cannabis legislation around the world continues to evolve. Additionally, there is also focus on the forthcoming Cannvas.Pet platform, designed to help pet owners explore the use of medical cannabis to help treat their pet's ailments.

"A crucial aspect of cannabis legalization that has been overlooked since its October inception is access to free and unbiased education around the plant and an opportunity for Canadians to learn for themselves whether or not it can be a beneficial part of their lifestyle," said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. "We strive to elevate cannabis learning and open the public's eyes to the myriad health care benefits the plant offers, better contextualizing its place in our culture and delivering evidence-backed education from a team of certified health practitioners and educators."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.

CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

For additional information, please visit: http://www.clsholdingsinc.com

Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411

Investorideas.com - Companies Betting on the #CBD #Pet Market; Canopy (TSX: $WEED.TO), (NYSE: $CGC), CannTrust (TSX: $TRST.TO), EnviroTechnologies (OTC: $ETII), Isodiol (CSE: $ISOL.C) (OTC: $ISOLF)

Companies Betting on the #CBD #Pet Market; Canopy (TSX: $WEED.TO), (NYSE: $CGC), CannTrust (TSX: $TRST.TO), EnviroTechnologies (OTC: $ETII), Isodiol (CSE: $ISOL.C) (OTC: $ISOLF)

Congress Passes $867 billion Farm Bill

Point Roberts, WA and Delta, BC - December 13, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity for the CBD pet market and how companies that are positioned in the cannabis space are adding pet markets to their growing portfolios.

According to the American Pet Products Association (APPA), $69.51 billion was spent on pets in the U.S in 2017 and it's estimated that number will grow to $72.13 billion for 2018. Canadians spend $6.6 billion a year on their pets according to recent numbers.

Looking at how cannabis/CBD plays into the pet market, CTV reported, "In 2017, sales of cannabis products marketed for pets at medical and adult-use cannabis dispensaries was nearly $7 million in California, Colorado, Oregon and Washington, according to BDS Analytics. In Colorado, sales of pet products grew 49 per cent in 2017, versus growth across all product categories at 15 per cent, it said."

Canopy Animal Health, stated as the global leader in cannabinoid science for pets, is a a division of Canopy Health, a wholly owned subsidiary of Canopy Growth Corporation (TSX:WEED), (NYSE:CGC). In August they announced that approval had been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol ("CBD") to treat anxiety in certain animals.

Continued: The research will be conducted by Canopy Animal Health, a division of Canopy Health which focuses on developing cannabis-based healthcare products for companion animals. The approval comes in the form of a No Objection Letter for the use of a proprietary CBD enriched oil formulation, previously administered in preclinical dosing and safety studies, as a potential therapy for anxiety. The CBD formulation will be produced by Canopy Growth in its GMP-certified production facility in Smiths Falls, Ontario.

From the release: "Our passion to create safe and effective products for animals is driven by the love we share for our pets," commented Marc Wayne, Managing Director, Canopy Health

Innovations. "The use of natural-occurring cannabinoids as a therapy for companion animals is a logical new forefront of medical discovery and the research we are working on at CAH is world leading. These trial approvals mark a significant milestone on the journey of making cannabis-based drugs accepted and recommended by veterinarians."

Trying to set their own paw print in the sector, EnviroTechnologies International, Inc. (OTC: ETII) , just reported that its subsidiary, CBD Health Co., (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, is progressing in its hemp-based pet supplement products development.

From the news: "Much has been written lately about CBD products and the numerous applications for humans and pets, which has raised consciousness of CBD's therapeutic value. Our CBD products are all cannabidiol-based, which means they are not psychoactive and are safe for pets," said Joe De Leon, CBD's President. "When your pet gets sick, you want the best treatment available and the products we are developing will offer better, more effective and safer medicinal options for pets than traditional pet health products."

Continued: Current research shows that there are several common CBD benefits for dogs, which are, 1) powerful painkiller (the ECS is involved in managing pain and CBD's pain killing properties are well documented); 2) effective anticonvulsant (CBD helps control seizures, tremors, tics and spasms); 3) natural anti-inflammatory; 4) anxiety and stress reducer (anxiety in dogs often results in barking, urination and defecation, chewing and aggression); 5) active antiemetic (reduces nausea and vomiting); and homeostasis promoter (proper functioning of the body).

"Pet owners are committed to their pet's health and well-being and are willing to spend money on pet health products, which make this a multi-billion dollar market, worldwide," said Karren. "We hope to introduce our CBD pet products in 2019 as we believe that our CBD pet products will be superior to those currently offered in this huge industry and will create another profitable channel for our CBD products."

Earlier this year, CannTrust Holdings Inc. (TSX: TRST), one of Canada's leading licensed producers of medical cannabis, announced it entered into a letter of intent with privately-owned company, Grey Wolf Animal Health Inc., to develop groundbreaking cannabis products to support the well-being of pets.

From the news: There are approximately 16 million cats and dogs in Canada with almost two-thirds of Canadian households owning a pet. Canadian pet owners are increasingly treating pets as an extension of their family. With over 350 million pets globally, there is a sizeable market opportunity for cannabis products.

Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) announced in October it will be launching Pawceuticals, a CBD-based product line that naturally aids in restoring a pet's health and improving overall wellness.

While these companies are not solely focused on the pet market, it is another revenue door to open in the CBD market. Investors and industry leaders see further substantial growth for the sector as the $867 billion Farm Bill

Was just passed by Congress yesterday.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ETII is a paid for news release on Investorideas.com - third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com

800-665-0411

Investorideas.com - CLS Holdings USA (OTCQB: $CLSH) Closes approximately $12 Million Private Placement of Convertible Debentures

CLS Holdings USA (OTCQB: $CLSH) Closes approximately $12 Million Private Placement of Convertible Debentures

Investorideas.com featured cannabis company - CLS Holdings USA, Inc. (OTCQB: CLSH)

LAS VEGAS - December 13, 2018 (Investorideas.com Newswire) CLS Holdings USA, Inc. (CLSH) "CLS," a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries, today announced the closing of an approximately $12 million private placement (the "Offering") of 8% senior unsecured convertible debentures (the "Convertible Debentures").

The Offering, conducted by a syndicate of underwriters, was priced at $1,000 per convertible debenture. The Convertible Debentures are convertible into units (each, a "Unit") at a price of $0.80 per Unit. Each Unit is comprised of one common share of the Company (a "Common Share") and one half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant shall be exercisable for one Common Share at a price of $1.10 per Warrant (the "Exercise Price") for a period of 36 months from the closing date.

The proceeds of the financing will be used to continue to execute the Company’s growth strategy in Nevada and Massachusetts.

As previously announced, CLS has entered into an agreement with a Canadian agent. This closing represents the first tranche raised under such agreement.

This is not an offer for sale, or solicitation of an offer to buy, nor may there be any sale in the United States or to, or for the account or benefit of, any U.S. Person (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) of any securities of the Company prior to compliance with any applicable securities laws.

Neither the Convertible Debentures nor the Units, Common Shares or Warrants issuable upon conversion of the Convertible Debentures or the Common Shares issuable upon exercise of the Warrants have been or will be registered under the U.S. Securities Act, or any securities laws of any state of the United States and may not be offered or sold absent such registration or an applicable exemption from such registration requirements.

About Oasis Cannabis

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.

About CLS Holdings USA, Inc.

Forward Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. These forward-looking statements include, but are not limited to, statements relating to its ongoing Convertible Debenture financing and whether and when certain transactions will be completed, the Company’s use of proceeds and its growth strategy in Nevada and Massachusetts, and anticipated license approvals. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filing with the SEC for additional details.

Contact Information

Corporate:
Chairman and CEO
Jeff Binder
jeff@clsholdingsinc.com
888-438-9132

Investors:
Hayden IR
CLSH@haydenir.com
917-658-7878

Disclosure: this podcast is a paid for distribution on Investorideas and social media. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: CSLH is a paid PR, news and social media client of Investorideas.com and is this month's exclusive sponsor of our daily cannabis potcast.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Wednesday, December 12, 2018

Investorideas.com - CV Sciences, Inc. Receives Nutritional Outlook's 2018 Best of the Industry Award

Investorideas.com - CV Sciences, Inc. Receives Nutritional Outlook's 2018 Best of the Industry Award

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: GTEC Holdings (TSXV: GTEC) (OTCQB: GGTTF) Announces OTCQB Listing and DTC Eligibility

Investorideas.com - #Cannabisstocks: GTEC Holdings (TSXV: GTEC) (OTCQB: GGTTF) Announces OTCQB Listing and DTC Eligibility

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - CSE New #Cannabis Listing - High Tide Inc. (HITI)

Investorideas.com - CSE New #Cannabis Listing - High Tide Inc. (HITI)

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - CSE New #Cannabis Listing - The Yield Growth Corp. (BOSS)

Investorideas.com - CSE New #Cannabis Listing - The Yield Growth Corp. (BOSS)

Get the latest Cannabis and Hemp stock news from www.investorideas.com

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .